MiNK Therapeutics, Inc.·4

Jun 16, 8:11 PM ET

Corvese Brian 4

4 · MiNK Therapeutics, Inc. · Filed Jun 16, 2023

Insider Transaction Report

Form 4
Period: 2023-06-14
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-06-14+37,50037,500 total
    Exercise: $2.27Exp: 2033-06-14Common Stock (37,500 underlying)
Footnotes (1)
  • [F1]The option vests in full on the one-year anniversary of the date of grant, provided that the Reporting Person continues to serve on the Issuer's Board of Directors through such date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION